QurAlis at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
QurAlis takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on drugs for the brain and spinal cord, and on getting them across the blood-brain barrier and past the translational hurdles of nonclinical development.
| Organization | ACT 2026 Attendance |
|---|---|
QurAlis Cambridge, MA | |
Biotech developing precision medicines for ALS, frontotemporal dementia and other neurodegenerative diseases. | Talk Tue Nov 17 9:00am–9:05am Session Tue Nov 17 9:00am–12:00pm Overcoming the Blood-Brain Barrier and Translational Challenges in the Nonclinical Development of CNS Drugs (S08)
|
Instantly find 20 buyers from QurAlis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction